Insilico Medicine is a biotechnology company that uses artificial intelligence to discover new drugs and develop personalized medicine. The company was founded in 2014 by Alex Zhavoronkov and has partnerships with pharmaceutical companies including Pfizer and GSK. Insilico Medicine has raised over $52 million in funding from investors including Qiming Venture Partners and WuXi AppTec.